Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Tipo de estudo
Intervalo de ano
2.
Qatar Medical Journal. 2007; 16 (2): 68-69
em Inglês | IMEMR | ID: emr-100455

RESUMO

Lipid-lowering agents such as HMG-CoA reductase inhibitors [also known as statin drugs] are generally well tolerated. But a recognized side effect still can happen, We report a case of 47-year-old Iraqi male patient previously known hypothyroid, was not on replacement therapy, as he did not appear after his thyroid functions was checked came in with severe body pain for 10 months got worse in the last three months, started on lipostat [ten months ago] found to have myopathy as evident by high CPK which improved gradually clinically and biochemical after stopping lipostat


Assuntos
Humanos , Masculino , Pravastatina , Doenças Musculares/etiologia , Inibidores de Hidroximetilglutaril-CoA Redutases , Hipolipemiantes , Creatina Quinase , Doenças Musculares/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA